Metformin

Metformin is a biguanide medication and the globally recognized first-line therapy for the management of type 2 diabetes (T2DM). Beyond its primary role in glycemic control, it is increasingly studied for its pleiotropic effects, meaning it impacts multiple biological pathways simultaneously. It is one of the most widely prescribed and cost-effective drugs in history, frequently used off-label for conditions like Polycystic Ovary Syndrome (PCOS) and prediabetes. Recently, it has gained significant attention in the wellness and longevity community for its potential to delay the onset of age-related diseases.

Metformin's mechanism is multi-faceted and involves several organs:

• Liver: It primarily suppresses gluconeogenesis, reducing the amount of sugar the liver produces and releases into the bloodstream.
• Muscle Tissue: It enhances insulin sensitivity, allowing muscle cells to take up and utilize glucose more efficiently.
• Mitochondria: It mildly inhibits Complex I of the mitochondrial respiratory chain, which increases the AMP/ATP ratio, thereby activating AMPK (an energy sensor that promotes fat burning and metabolic health).
• Gut Microbiota: It alters the composition of the gut microbiome (notably increasing Akkermansia muciniphila) and stimulates the secretion of GLP-1, a hormone that regulates appetite and blood sugar.
• Brain: Emerging 2025 research has identified a pathway in the hypothalamus (specifically the Rap1 protein) that allows metformin to regulate whole-body glucose metabolism through the central nervous system.

Based on 2024-2025 clinical guidelines and recent research, users should follow these safety protocols:

• Standard Use: For type 2 diabetes, metformin remains a foundation, though it is now often combined early with SGLT2 inhibitors or GLP-1 agonists to maximize cardiovascular and renal protection.
• Dosing Strategy: To minimize gastrointestinal side effects, clinical consensus recommends a "start low, go slow" approach, typically beginning with 500mg once daily and titrating upward over several weeks.
• Mitigation of Side Effects: Take the medication with a meal to reduce nausea and diarrhea. Extended-release (ER) versions are often better tolerated than immediate-release forms.
• Vital Monitoring: Long-term users (especially >1 year) should have Vitamin B12 levels tested annually, as metformin can interfere with B12 absorption. Supplementation may be necessary to prevent neuropathy and anemia.
• Renal Safety: Renal function (eGFR) must be monitored; it is generally contraindicated if eGFR falls below 30 mL/min/1.73m² due to the risk of lactic acidosis.